These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25092708)

  • 41. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
    Chen YH; Lu PL; Huang CH; Liao CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1452-7. PubMed ID: 22203598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Highly Tigecycline-Resistant Klebsiella pneumoniae Sequence Type 11 (ST11) and ST147 Isolates from Companion Animals.
    Ovejero CM; Escudero JA; Thomas-Lopez D; Hoefer A; Moyano G; Montero N; Martin-Espada C; Gonzalez-Zorn B
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in Klebsiella pneumoniae.
    Lv L; Wan M; Wang C; Gao X; Yang Q; Partridge SR; Wang Y; Zong Z; Doi Y; Shen J; Jia P; Song Q; Zhang Q; Yang J; Huang X; Wang M; Liu JH
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of Efflux Pumps AcrAB and OqxAB Contributes to Ciprofloxacin Resistance in Clinical Isolates of
    Albarri O; AlMatar M; Öcal MM; Köksal F
    Curr Protein Pept Sci; 2022; 23(5):356-368. PubMed ID: 35786184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [In vitro activity of tigecycline against multiple resistant Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae isolates].
    Arikan Akan O; Uysal S
    Mikrobiyol Bul; 2008 Apr; 42(2):209-15. PubMed ID: 18697418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of Efflux Pumps Mediate Pan Resistance of
    Lv F; Cai J; He Q; Wang W; Luo Y; Wang X; Mi N; Zhao Z; Li G; Luo W
    Microb Drug Resist; 2021 Oct; 27(10):1405-1411. PubMed ID: 33835874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tigecycline-non-susceptible hypervirulent Klebsiella pneumoniae strains in Taiwan.
    Cheng YH; Huang TW; Juan CH; Chou SH; Tseng YY; Chen TW; Yang TC; Lin YT
    J Antimicrob Chemother; 2020 Feb; 75(2):309-317. PubMed ID: 31702790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae.
    Zheng JX; Lin ZW; Sun X; Lin WH; Chen Z; Wu Y; Qi GB; Deng QW; Qu D; Yu ZJ
    Emerg Microbes Infect; 2018 Aug; 7(1):139. PubMed ID: 30068997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.
    Lim TP; Cai Y; Hong Y; Chan EC; Suranthran S; Teo JQ; Lee WH; Tan TY; Hsu LY; Koh TH; Tan TT; Kwa AL
    Antimicrob Agents Chemother; 2015 May; 59(5):2515-24. PubMed ID: 25691628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in
    Chen Y; Hu D; Zhang Q; Liao XP; Liu YH; Sun J
    Front Cell Infect Microbiol; 2017; 7():37. PubMed ID: 28261566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods.
    Osei Sekyere J; Govinden U; Bester LA; Essack SY
    J Appl Microbiol; 2016 Sep; 121(3):601-17. PubMed ID: 27153928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Spanu T; De Angelis G; Cipriani M; Pedruzzi B; D'Inzeo T; Cataldo MA; Sganga G; Tacconelli E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4516-8. PubMed ID: 22644031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ramR loss-of-function insertion on tigecycline resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae.
    Mao Y; Shi Q; Zhang P; Jiang Y; Yu Y
    J Glob Antimicrob Resist; 2020 Jun; 21():410-413. PubMed ID: 32006749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae.
    Veleba M; Higgins PG; Gonzalez G; Seifert H; Schneiders T
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4450-8. PubMed ID: 22644028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae.
    Keeney D; Ruzin A; Bradford PA
    Microb Drug Resist; 2007; 13(1):1-6. PubMed ID: 17536927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.
    Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A
    Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
    Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
    Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.